These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 966670)

  • 1. [Clinical value of determining fibrin and fibrinogen degradation products in kidney diseases].
    Belitskaia GA; Ena IaM; Varetskaia TV; Shevchenko LI
    Klin Med (Mosk); 1976 Mar; 54(3):96-102. PubMed ID: 966670
    [No Abstract]   [Full Text] [Related]  

  • 2. Specific identification of urinary fibrinogen, fibrinogen degradation products, and cross-linked fibrin degradation products in renal diseases and after renal allotransplantation.
    Scott WL; Francis CW; Knutson DW; Marder VJ
    J Lab Clin Med; 1986 Jun; 107(6):534-43. PubMed ID: 3519810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The usefullness of the fibrinogen degradation products (FDP) determination in the serum and urine in diagnostics and evaluation of effectiveness of therapy of nephropathy (author's transl)].
    Kwiecien-Głowacka E
    Przegl Lek; 1981; 38(3):335-40. PubMed ID: 7244292
    [No Abstract]   [Full Text] [Related]  

  • 4. Fibrinogen-fibrin degradation products in renal disorders.
    Dube B; Srivastava PK; Padmanabhan R; Dube RK
    Indian J Pathol Microbiol; 1979 Oct; 22(4):313-22. PubMed ID: 548482
    [No Abstract]   [Full Text] [Related]  

  • 5. [Clinical importance of determining fibrinogen and fibrin breakdown products in arterial hypertension].
    Ena IaM; Chernysheva LG; Taran AI; Shevchenko LI
    Sov Med; 1981; (3):6-9. PubMed ID: 7244836
    [No Abstract]   [Full Text] [Related]  

  • 6. Significance of the quantitative determination of "fibrin degradation products" in renal diseases.
    Chin Med J (Engl); 1980 Jul; 93(7):483-6. PubMed ID: 6772396
    [No Abstract]   [Full Text] [Related]  

  • 7. [Fibrin degradation products in the urine in renal diseases].
    Iversen BM; Ofstad J; Thunold S; Willassen Y
    Tidsskr Nor Laegeforen; 1976 Jan; 96(2):91-3. PubMed ID: 766292
    [No Abstract]   [Full Text] [Related]  

  • 8. [Studies on intraglomerular coagulation in various renal diseases].
    Shibata T
    Nihon Jinzo Gakkai Shi; 1985 Nov; 27(11):1535-47. PubMed ID: 3831470
    [No Abstract]   [Full Text] [Related]  

  • 9. [Determination of fibrin and fibrinogen split products by their anticoagulant activity].
    Belitser VA; Varetskaia TV; Tsynkalovskaia SN; Tsariuk LA; Shevchenko LI
    Ukr Biokhim Zh; 1976; 48(4):521-32. PubMed ID: 982623
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Relations between products of fibrin degradation and arterial blood pressure in pregnancy complicated by nephropathy].
    Tsitsiashvili ESh
    Lab Delo; 1982; (4):230-2. PubMed ID: 6177910
    [No Abstract]   [Full Text] [Related]  

  • 11. [Possibilities of using immunoenzyme test systems for determining levels of myoglobin, fibrinogen, fibrin-fibrinogen degradation products and fibronectin in the diagnosis of somatic diseases].
    Ermolin GA; Shelepova TM; Dikov MM; Osmanov SK; Voloshchuk OM
    Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1987; 10(1):33-7. PubMed ID: 3300700
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical significance of urinary fibrin-fibrinogen degradation products in renal disease].
    Umitsu Y
    Nihon Jinzo Gakkai Shi; 1976 Jun; 18(6):371-87. PubMed ID: 988340
    [No Abstract]   [Full Text] [Related]  

  • 13. [Quantitative analysis of crosslinked fibrin degradation products (XDP) in several diseases].
    Saito M; Asakura H; Ito K; Joukaji H; Uotani C; Kumabashiri I; Matsuda T
    Rinsho Ketsueki; 1988 Nov; 29(11):2042-7. PubMed ID: 3236412
    [No Abstract]   [Full Text] [Related]  

  • 14. [Fibrin fibrinogen degradation products and their significance in kidney diseases (literature review)].
    Peleshchuk AP; Belitskaia GA; Ena IaM; Drannik GN
    Vrach Delo; 1979 Aug; (8):1-5. PubMed ID: 384672
    [No Abstract]   [Full Text] [Related]  

  • 15. [Study of fibrinogen degradation products in rheumatic diseases].
    Murav'ev IuV
    Ter Arkh; 1980; 52(6):84-7. PubMed ID: 7404395
    [No Abstract]   [Full Text] [Related]  

  • 16. ["Paracoagulation" phenomenon and fibrin- fibrinogen degradation products in acute poisoning with acetic acid].
    Kuznetsova AV
    Ter Arkh; 1977; 49(6):139-43. PubMed ID: 898038
    [No Abstract]   [Full Text] [Related]  

  • 17. [Method of radial immunodiffusion by Mancini for determination of fibrin fibrinogen degradation products].
    Mikhaĭlova ND; Guseĭnov ChS; Likhacheva ZI; Gorelova AM
    Lab Delo; 1978; (8):490-3. PubMed ID: 80505
    [No Abstract]   [Full Text] [Related]  

  • 18. Fibrin-fibrinogen degradation products in hepatic cirrhosis.
    Bulajić M; Kovacević N; Lalić M; Rolović Z
    Acta Med Iugosl; 1977; 31(4):333-8. PubMed ID: 596236
    [No Abstract]   [Full Text] [Related]  

  • 19. [A comparative evaluation of methods for determining the activity of rheumatic diseases].
    Belitskaia GA; Nikula TD; Palienko IA; Shevchenko LI; Fedorova NE
    Vrach Delo; 1989 Aug; (8):25-7. PubMed ID: 2588517
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Differential examination of the serous fluid and key points in clinical tests].
    Takayanagi N
    Rinsho Byori; 1983 Sep; 31(9):927-33. PubMed ID: 6663768
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.